J. Martin Carroll - Jun 1, 2022 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
Director
Signature
/s/ Sheldon L. Koenig
Stock symbol
ESPR
Transactions as of
Jun 1, 2022
Transactions value $
$0
Form type
4
Date filed
6/1/2022, 04:24 PM
Previous filing
Dec 1, 2021
Next filing
Jun 3, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ESPR Stock Option (right to buy) Award $0 +40K $0.00 40K Jun 1, 2022 Common Stock 40K $5.42 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The awards vest over a three (3) year period in equal annual installments, the first of which will be June 1, 2023.